SCHEMBL23020736

SCHEMBL23020736

COc1ccc(Nc2ncc3c(n2)CNC3)cc1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK5 Q00535 2/20 0.66
CDK5R1 Q15078 2/20 0.66
GRM5 P41594 1/20 0.55
ALDH1A1 P00352 4/20 0.53
MAOA P21397 3/20 0.53
MAOB P27338 3/20 0.53
KDM4E B2RXH2 2/20 0.53
USP2 O75604 1/20 0.53
HPGD P15428 1/20 0.53
CASP1 P29466 1/20 0.53
CASP7 P55210 1/20 0.53
SMN1; SMN2 Q16637 1/20 0.53
HSD17B10 Q99714 1/20 0.53
AURKA O14965 2/20 0.52
SYK P43405 1/20 0.52
KDR P35968 8/20 0.50
MAPT P10636 2/20 0.49
PLK1 P53350 3/20 0.49
CYP1A2 P05177 1/20 0.49
CYP3A4 P08684 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL22999875 0.99 CDK5 (0.64) CDK5CDK5R1GRM5ALDH1A1MAOA
SCHEMBL9959983 0.88 CDK5 (0.69) CDK5CDK5R1GRM5ALDH1A1MAOA
SCHEMBL22999829 0.86 CDK5 (0.51) CDK5CDK5R1GRM5ALDH1A1KDM4E
SCHEMBL23020822 0.85 CDK5 (0.69) CDK5CDK5R1USP2AURKASYK
SCHEMBL23021156 0.85 CDK2 (0.63) CDK5CDK5R1GRM5ALDH1A1MAOB
Hydrochloric Acid SCHEMBL22999667 0.84 CDK5 (0.67) CDK5CDK5R1USP2AURKASYK
Hydrochloric Acid SCHEMBL22999614 0.83 CDK2 (0.62) CDK5CDK5R1GRM5ALDH1A1MAOB
SCHEMBL23020725 0.83 CTSC (0.51) CDK5CDK5R1SYKCDK2
SCHEMBL23020744 0.82 AURKA (0.51) CDK5CDK5R1GRM5ALDH1A1SMN1; SMN2
SCHEMBL17106477 0.81 CDK5 (0.61) CDK5CDK5R1GRM5ALDH1A1MAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3782997-A1 FUSED PYRIMIDINE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF FIBROTIC DISEASES Galapagos N.V. (BE) 2021-02-24 EP disclosed